wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35206815-3728C021-32C7-4C52-968A-DB9E5BD2BA57
Q35206815-3728C021-32C7-4C52-968A-DB9E5BD2BA57
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35206815-3728C021-32C7-4C52-968A-DB9E5BD2BA57
Low rates of bone mineral density measurement in Medicare beneficiaries with prostate cancer initiating androgen deprivation therapy
P2860
Q35206815-3728C021-32C7-4C52-968A-DB9E5BD2BA57
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35206815-3728C021-32C7-4C52-968A-DB9E5BD2BA57
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
49828afd19d39f6ddb07ea212f3ab8fb8eae85cf
P2860
Risedronate prevents early bone loss and increased bone turnover in the first 6 months of luteinizing hormone-releasing hormone-agonist therapy for prostate cancer.